Practical Molecular Pathology for the Surgical Pathologist
Masters of Pathology Series
A comprehensive CME program designed to enhance your understanding of molecular pathology and its role in targeted cancer therapy. Earn Lifelong Learning and SAM credits.
Stay Current with Major Advances
This CME course in molecular pathology is extremely thorough, covering a range of hot topics and core concepts in the field aiming to facilitate detection, diagnosis and treatment of cancer. Practical Molecular Pathology for the Surgical Pathologist focuses on the latest molecular techniques, recently identified molecular genetic alterations in cancer, tissue triaging for molecular testing etc. helping you to better:
- Identify molecular genetic alteration in a broad range of cancer types
- Understand the implications of molecular genetic testing results for cancer therapy
- Apply immunohistochemistry based on molecular genetic changes to classify tumors
- emistry based on molecular genetic changes to classify tumors
- Interpret the results and implications of PD-L1 immunohistochemistry and mismatch repair protein assessments
QUICK FACTS
Provider: Oakstone
Course Director:
Jason L. Hornick, MD, PhD
Professor of Pathology
Harvard Medical School
Director of Surgical Pathology and
Immunohistochemistry
Brigham & Women's Hospital
Learning Objectives
Upon completion of this activity, the participant will be able to:
- Recognize the most common molecular genetic alterations in a wide range of cancer types
- Understand the implications of molecular genetic testing results for cancer therapy
- Apply immunohistochemistry based on molecular genetic alterations to help in tumor classification
- Interpret the results and implications of PD-L1 immunohistochemistry and mismatch repair protein assessments
Intended Audience
Pathology residents and practicing pathologists without formal molecular pathology training/fellowship.
TOPICS/SPEAKERS
- Introduction to Molecular Pathology for Surgical Pathologists - Lynette M. Sholl, MD
- Molecular Pathology of Thoracic Tumors - Lynette M. Sholl, MD
- Assessment of PD-L1 and Mismatch Repair Deficiency in the Immunotherapy Era - Lynette M. Sholl, MD
- Molecular Pathology of Colorectal Carcinoma - Jonathan A. Nowak, MD, PhD
- Molecular Pathology of Uterine Tumors - Brooke E. Howitt, MD
- Molecular Pathology of Melanocytic Tumors - Aleodor Andea, MD, MBA
- Molecular Pathology of Head and Neck Carcinomas - William Faquin, MD, PhD
- Molecular Pathology of Salivary Gland Tumors - Justin A. Bishop, MD
- Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Molecular Basis and Implications for Molecular Testing of Thyroid Nodules - Justine Barletta, MD
- Clinical Implications of Molecular Alterations in Thyroid Tumors, Pheochromocytomas, and Paragangliomas - Justine Barletta, MD
- Molecular Pathology of Brain Tumors - Arie Perry, MD
- Molecular Pathology of Renal Tumors - Sean R. Williamson, MD
- Molecular Pathology of Sarcomas - Jason L. Hornick, MD, PhD
- Molecular Pathology of Lymphoid Neoplasms - Dennis P. O'Malley, MD
- Molecular Pathology of Myeloid Neoplasms - Todd Barry, MD, PhD
Date of Original Release: September 1, 2018
Date Credits Expire: September 1, 2021